USSTOCK.TODAY
Market Closed
Log in Sign up

Cellectar Biosciences records $0.46 loss per share in Q3

Earnings Whispers · ·by G4L

CLRB
CLRB Cellectar Biosciences Inc
$1.21 -0.82%
View chart & analysis →
  1. 1Cellectar Biosciences Inc recorded a loss of $0.46 per share in the third quarter.
  2. 2Cellectar Biosciences Inc's net loss was $8 million, nearly doubling from the previous net loss of $4.4 million.
  3. 3The 67.4% year-over-year revenue growth for Cellectar Biosciences Inc reflects stock dilution rather than operational improvement.

So what's the key point?

Cellectar Biosciences Inc reported a loss of $0.46 per share in the third quarter. The loss amount nearly doubled compared to before, which is not good news for investors.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Autolus Therapeutics reports Q3 revenue growth and raises AUCATZYL guidance Earnings Whispers · 15m agoAviat Networks records Q1 loss due to declining profitability despite record orders Earnings Whispers · 15m agoBrainsWay Misses Third Quarter Earnings and Revenue Estimates Earnings Whispers · 15m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news